Back to results
US 2026/0216350 A1Published application
Insulin complexes
AssigneeUniversity of Notre Dame du Lac
InventorsMatthew J. Webber, Yuanhui Xiang, Sijie Xian
Life of this patent
Estimating the term…
Abstract
Described are complexes comprising insulin. The complexes described herein comprise insulin or a macromolecule attached to a glucose-binding diboronate motif (B1), and a macromolecule or insulin attached to a diol (D1). Further disclosed are methods of correcting blood glucose levels in a subject in need thereof, the methods comprising administering a complex described herein or a pharmaceutical composition comprising a complex described herein to the subject in need thereof.
Claims22
A complex comprising:
- insulin attached to B1 (insulin-B1) and a macromolecule attached to D1 (macromolecule-D1);
- or
- insulin attached to D1 (insulin-D1) and a macromolecule attached to B1 (macromolecule-B1);
- wherein:
- B1 is
- wherein:
- BX, at each occurrence, is B(OH)2 or [B(OH)3]—;
- G1, at each occurrence, is independently a pyridylene or a phenylene, wherein G1 is optionally substituted with 1-2 substituents independently selected from the group consisting of halogen, —CN, C1-4alkyl, —NO2, C3-4cycloalkyl, C1-2haloalkyl, —OC1-4alkyl, —OC3-4cycloalkyl, and —OC1-2haloalkyl, wherein each cycloalkyl is optionally substituted with 1-4 substituents independently selected from the group consisting of halogen, C1-4alkyl, and C1-2haloalkyl;
- L12, at each occurrence, is independently a C1-6alkylene wherein optionally 1-2 methylene groups in the alkylene of L12 are independently replaced with —N(H)—, —O—, or —S—, wherein 2 methylene groups replaced with —N(H)—, —O—, or —S— are separated by two or more carbon atoms in the alkylene;
- and
- G2 is phenylene, wherein G2 is optionally substituted with a first substituent selected from the group consisting of halogen, cyano, C1-6alkyl, C1-4haloalkyl, oxo, —OR2x, —N(R2x)2, —SR2x, —SO2R2x, —C(O)R2x, —C(O)OR2x, —C(O)N(R2x)2, —C1-6alkylene-OR2x, —C1-6alkylene-SR2x, —C1-6alkylene-N(R2x)2, —C1-6alkylene-SO2R2x, —C1-6alkylene-C(O)R2x, —C1-6alkylene-C(O)OR2x, and —C1-6alkylene-C(O)N(R2x)2, and optionally further substituted with 1-3 substituents independently selected from the group consisting of halogen, cyano, C1-4alkyl, C1-4haloalkyl, and —OR2x;
- R2x, at each occurrence, is hydrogen, C3-4cycloalkyl, C1-2haloalkyl, —OC1-4alkyl, —OC3-4cycloalkyl, or —OC1-2haloalkyl, wherein each cycloalkyl is optionally substituted with 1-4 substituents independently selected from the group consisting of halogen, C1-4alkyl, and C1-2haloalkyl;
- and
- D1 is a diol moiety comprising
11 more elements
(canceled)
Dependencies are inferred from the claim text.